Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments.
Gupta A, Konnova A, Smet M, Berkell M, Savoldi A, Morra M, Van Averbeke V, De Winter FH, Peserico D, Danese E, Hotterbeekx A, Righi E; mAb ORCHESTRA working group; De Nardo P, Tacconelli E, Malhotra-Kumar S, Kumar-Singh S.
Gupta A, et al.
J Clin Invest. 2023 Mar 15;133(6):e166032. doi: 10.1172/JCI166032.
J Clin Invest. 2023.
PMID: 36727404
Free PMC article.